Charles Albright

2016

In 2016, Charles Albright earned a total compensation of $2.7M as Chief Scientific Officer at Editas Medicine.

Compensation breakdown

Non-Equity Incentive Plan$44,297
Option Awards$2,506,028
Salary$136,538
Total$2,686,863

Albright received $2.5M in option awards, accounting for 93% of the total pay in 2016.

Albright also received $44.3K in non-equity incentive plan and $136.5K in salary.

Rankings

In 2016, Charles Albright's compensation ranked 3,632nd out of 14,075 executives tracked by ExecPay. In other words, Albright earned more than 74.2% of executives.

ClassificationRankingPercentile
All
3,632
out of 14,075
74th
Division
Manufacturing
1,270
out of 5,486
77th
Major group
Chemicals And Allied Products
393
out of 1,900
79th
Industry group
Drugs
287
out of 1,543
81st
Industry
Biological Products, Except Diagnostic Substances
56
out of 287
81st
Source: SEC filing on April 26, 2017.

Albright's colleagues

We found two more compensation records of executives who worked with Charles Albright at Editas Medicine in 2016.

2016

Gerald Cox

Editas Medicine

Chief Medical Officer

2016

Katrine Bosley

Editas Medicine

Chief Executive Officer

News

In-depth

You may also like